4 completed, 1 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Terminated 1 |
Follow telavancin: new trials by email Literature Review of telavancin trials Research Report on telavancin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial Telavancin, Vancomycin, Daptomycin - Bacteremia | Phase 3 | Terminated | Cumberland Pharmaceuticals | 121 | 2014-12-01 | 2020-02-17 |
| Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Staphylococcal Skin Infection | Phase 3 | Completed | Cumberland Pharmaceuticals | 1035 | 2005-02-01 | 2019-01-16 |
| Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Bacterial Pneumonia | Phase 3 | Completed | Cumberland Pharmaceuticals | 761 | 2005-02-01 | 2019-01-16 |
| Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Staphylococcal Skin Infection | Phase 3 | Completed | Cumberland Pharmaceuticals | 862 | 2005-01-01 | 2019-01-16 |
| Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Bacterial Pneumonia | Phase 3 | Completed | Cumberland Pharmaceuticals | 771 | 2005-01-01 | 2019-01-16 |
Staphylococcal Infections (3) · Pneumonia, Bacterial (2) · Staphylococcal Skin Infections (2) · Bacteremia (1) · Healthcare-Associated Pneumonia (1)
Cumberland Pharmaceuticals (5)
United States (4) · Israel (1)
PMID 18444791, PMID 19095213, PMID 22416054, PMID 24708675, PMID 27718118, PMID 29454592